Breaking News Instant updates and real-time market news.

AMD

AMD

$25.19

0.14 (0.56%)

, FLEX

Flex

$13.90

0.005 (0.04%)

05:55
08/30/18
08/30
05:55
08/30/18
05:55

RBC Capital to hold a bus tour

Technology Bus Tour will travel throughout San Francisco visiting with various tech companies on August 28-30.

AMD

AMD

$25.19

0.14 (0.56%)

FLEX

Flex

$13.90

0.005 (0.04%)

HDP

Hortonworks

$22.66

1.25 (5.84%)

HPQ

HP Inc.

$25.08

0.6 (2.45%)

IMPV

Imperva

$47.85

0.75 (1.59%)

INTC

Intel

$48.74

0.16 (0.33%)

MU

Micron

$51.83

-0.52 (-0.99%)

NOW

ServiceNow

$200.29

6.04 (3.11%)

NTAP

NetApp

$86.26

0.32 (0.37%)

QLYS

Qualys

$91.05

-0.5 (-0.55%)

SQ

Square

$85.76

4.97 (6.15%)

SYMC

Symantec

$20.58

0.31 (1.53%)

TWTR

Twitter

$35.35

-0.14 (-0.39%)

WIX

Wix.com

$109.55

0.45 (0.41%)

ZEN

Zendesk

$69.27

2.02 (3.00%)

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 05

    Sep

  • 05

    Sep

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 18

    Sep

  • 20

    Sep

  • 01

    Oct

  • 06

    Nov

AMD AMD
$25.19

0.14 (0.56%)

08/23/18
RSBL
08/23/18
NO CHANGE
Target $30
RSBL
Buy
Rosenblatt boosts AMD price target to Street-high $30 from $27
After hosting institutional investor meetings last week with management, Rosenblatt analyst Hans Mosesmann raised his price target for AMD shares to $30 from $27. The chipmaker closed yesterday up 50c to $20.90. Mosesmann's new price target represents the high among Wall Street sell-side analysts. Following the meetings, Mosesmann has renewed conviction in AMD's multi-year double digit growth profile. Further, he's impressed by the analysis investors are doing in the name after years of disregard.
08/23/18
08/23/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ROSENBLATT BOOSTS AMD PRICE TARGET TO STREET HIGH: Rosenblatt analyst Hans Mosesmann raised his price target for AMD (AMD) shares to $30 from $27. Mosesmann's new price target represents the high among Wall Street sell-side analysts. Following the meetings, Mosesmann has renewed conviction in AMD's multi-year double digit growth profile. Further, he's impressed by the analysis investors are doing in the name after years of disregard. AMD is up 4.1% in late morning trading. CANTOR CUTS AETNA TO NEUTRAL: Cantor Fitzgerald analyst Steven Halper downgraded Aetna (AET) to Neutral from Overweight with a price target of $202. The stock now trades at just a 4.6% discount to the implied CVS Health (CVS) acquisition value of about $207 per share, Halper said. He believes the narrowed deal spread reflects an increased likelihood of regulatory approval. Halper cites limited potential upside for his downgrade of Aetna to Neutral. NIELSEN UPGRADED TO NEUTRAL AT GOLDMAN: Goldman Sachs analyst George Tong upgraded Nielsen Holdings (NLSN) to Neutral and raised his price target for the shares to $25 from $20. With activist Elliott Management pushing for a sale and increased deal activity in the Information Services sector, Tong sees increased likelihood of Nielsen being involved in a transaction. His upgrade to Neutral and price target increase come after the analyst incorporated a potential takeover into his model. Nielsen is up 3.3% in late morning trading. IMPERIAL SEES SUBSCRIBER UPSIDE FOR NETFLIX: Imperial Capital analyst David Miller believes Netflix's (NFLX) experiment with ending billing through Apple's (AAPL) app store in 33 countries outside the U.S. likely implies upside to its Q3 international subscriber guidance. The analyst said he has a tough time believing that Netflix would "experiment" with billing infrastructure mid-quarter if it did not believe that its international subscriber levels were trending ahead of guidance. As such, Miller raised his Q3 international subscriber estimate to 4.46M from 4.35M. He kept an Outperform rating on Netflix with a $494 price target. TARGET GETS UPGRADE AND DOWNGRADE: Target (TGT) was upgraded to Outperform from Market Perform at Telsey Advisory, and downgraded to Peer Perform from Outperform at Wolfe Research.
08/28/18
FBCO
08/28/18
NO CHANGE
Target $13.5
FBCO
Neutral
AMD shares 'more fully valued than cheap,' says Credit Suisse
While the transition to TSMC (TSM) for all 7nm products is a positive for AMD (AMD) given TSMC's "successful record of leading-edge manufacturing," AMD does not expect the transition to impact its long-term financial model, Credit Suisse analyst John Pitzer told investors last night in a research note. Further, the transition could have a dampening near-term financial impact as AMD has pre-negotiated annual purchase targets with GF thru 2020 that requires AMD to make quarterly payments based on the volume of wafers purchased from other foundries, the analyst adds. He notes that the departure of Jim Anderson, who is leaving AMD to become the CEO of Lattice Semiconductor (LSCC), is the latest executive departure at the company. While AMD's intellectual property is "extremely valuable" and investors continue to underestimate accelerating compute demand across all architectures, the stock appears "more fully valued than cheap" at current levels, Pitzer writes. The analyst maintains a Neutral rating on AMD with a $13.50 price target. The chipmaker in early trading is up 41c to $25.67.
08/29/18
MKMP
08/29/18
NO CHANGE
Target $20
MKMP
Neutral
Advanced Micro Devices price target raised to $20 from $13.50 at MKM Partners
MKM Partners analyst Ruben Roy raised his price target on Advanced Micro Devices (AMD) to $20, citing continued strength of the PC and data center end markets as well as his underestimated "new product momentum". The analyst also sees this week's expected announcement regarding a shift in 7nm production to TSMC (TSM) to benefit its long-term margin structure. Roy keeps his Neutral rating on AMD however, noting that its valuation of 38-times his expected forward earnings already reflects the high expectations.
FLEX Flex
$13.90

0.005 (0.04%)

06/18/18
STPT
06/18/18
UPGRADE
STPT
Buy
Flex upgraded to Buy from Hold at Standpoint Research
05/11/18
UBSW
05/11/18
NO CHANGE
Target $18
UBSW
Buy
Flex near-term may be pressured but long-term better, says UBS
UBS analyst Steven Milunovich said Flex boosted its capital expenditure guidance, which may pressure the shares in the near-term as the company ramps up its investment. The analyst noted bookings were strong across the board and guidance was unchanged, giving him confidence in the longer-term outlook for the shares. Milunovich reiterated his Buy rating and $18 price target on Flex shares.
04/27/18
04/27/18
DOWNGRADE

Market Perform
Flex downgraded to Market Perform, growth pushed out at Raymond James
As previously reported, Raymond James downgraded Flex two notches to Market Perform from Strong Buy following Q4 results. Analyst Adam Tindle said the outsized profit growth he expected in FY19 appears to be back half weighted, at best. Tindle would wait for better visibility into CEC growth, profitability with Nike, and improved utilization in broader CTG before becoming constructive on shares.
04/27/18
SBSH
04/27/18
NO CHANGE
Target $16
SBSH
Buy
Flex earnings selloff brings buying opportunity, says Citi
Flex's (FLEX) March quarter results were filled with several items that will be viewed by investors as bad news, including a delay in profitability ramp from Nike (NKE) and an unrelated accounting investigation resulting in the stock trading down 15% after hours, Citi analyst Jim Suva tells investors in a research note. The analyst believes the stock pressure is warranted following the 25% gain last year, but does not think these items are a "structural flaw to the company's operations or cash flows." As such, Suva views today's stock pullback as a buying opportunity. The Nike issue should be fully resolved within six months and the accounting investigation appears limited, he argues. The analyst lowered his price target for Flex to $16 from $20 and keeps a Buy rating on the name.
HDP Hortonworks
$22.66

1.25 (5.84%)

06/14/18
NOMU
06/14/18
INITIATION
Target $26
NOMU
Buy
Hortonworks initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Chris Eberle started Hortonworks with a Buy rating and $26 price target.
06/15/18
NOMU
06/15/18
INITIATION
Target $26
NOMU
Buy
Nomura Instinet starts Hortonworks with Buy rating, $26 price target
Nomura Instinet analyst Christopher Eberle last night initiated coverage of Hortonworks with a Buy rating and $26 price target. The company's fundamentally different approach to data management, progress on diversifying its revenue base, near-term path to breakeven operating cash flow, and continued improvement in operating metrics represent potential upside as management continues to execute, Eberle tells investors in a research note.
06/28/18
SBSH
06/28/18
INITIATION
Target $27
SBSH
Buy
Hortonworks initiated with a Buy at Citi
Citi analyst Tyler Radke started Hortonworks with a Buy rating and $27 price target. The analyst believes cloud risk is overdone and sees a favorable valuation relative to the company's growth.
08/08/18
NEED
08/08/18
NO CHANGE
Target $32
NEED
Buy
Hortonworks price target raised to $32 from $27 at Needham
Needham analyst Jack Andrews raised his price target on Hortonworks to $32 and kept his Buy rating after its Q2 earnings beat and raised FY18 revenue guidance. The analyst cites the company's positive momentum, driven by leverage in hybrid cloud architecture and product advancement supporting the multi-cloud workload. Andrews adds that Hortonworks stock price has "significantly underperformed" the Big Data software group in spite of its solid execution and this quarter could "serve as a catalyst for mean reversion opportunity".
HPQ HP Inc.
$25.08

0.6 (2.45%)

08/24/18
DBAB
08/24/18
NO CHANGE
Target $30
DBAB
Buy
HP Inc. price target raised to $30 from $27 at Deutsche Bank
Deutsche Bank analyst Sherri Scribner raised her price target for HP Inc. to $30 citing last night's better than expected fiscal Q3 results. Both the Personal Systems and Printing segments grew sales in the double-digits year-over-year, Scribner tells investors in a post-earnings research note. The analyst continues to see upside potential in the shares and keeps a Buy rating on the name. HP's consistent execution, strong free cash flow generation and growth opportunities are not reflected in the shares at current levels, Scribner contends.
08/24/18
LOOP
08/24/18
NO CHANGE
Target $28
LOOP
Buy
HP's normalized PC and printer economics are undervalued, says Loop Capital
Loop Capital analyst Ananda Baruah kept his Buy rating and $28 price target on HP Inc after its Q3 results, saying it was "another thesis confirming quarter" of "multiple undervalued aspects" to its investment story. The analyst notes specifically the "normalized" PC and Printer economics as well as "call option" opportunities around the new Industrial Printing and 3D Printing. Baruah contends that HP's revenue upside trajectory remains if the Office market can remain "flattish".
08/21/18
RBCM
08/21/18
NO CHANGE
Target $28
RBCM
Outperform
HP Q3 results have potential for modest upside, says RBC Capital
RBC Capital analyst Amit Daryanani kept his Outperform rating and $28 price target on HP Inc (HPQ) ahead of its Q3 earnings this Thursday. The analyst expects "in-line" results with "potential for modest upside" given the "stable" PC and printing data points during the quarter. Daryanani cites the first positive quarter of PC shipment growth in six years and relative HP outperformance as reported by Gartner. The analyst also points to the positive results from Canon (CAJ) and its Office segment.
08/21/18
LOOP
08/21/18
NO CHANGE
Target $28
LOOP
Buy
HP positioned well heading into 2019, says Loop Capital
Loop Capital analyst Ananda Baruah kept his Buy rating and $28 price target on HP Inc ahead of its earnings this week, saying he "really likes" the company's position heading into 2019. Baruah anticipates "ongoing solid results" from HP's normalized PC business after the latest round of data from IDC and Gartner on PC shipments. The analyst also points out the benefits of HP's recently acquired UK-based office equipment dealer Apogee, which is " meant to amplify" HP's commitment to the A3 copier market.
IMPV Imperva
$47.85

0.75 (1.59%)

07/27/18
DADA
07/27/18
DOWNGRADE
DADA
Neutral
Imperva downgraded to Neutral from Buy at DA Davidson
07/27/18
OPCO
07/27/18
DOWNGRADE
OPCO
Perform
Imperva downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Shaul Eyal downgraded Imperva to Perform from Outperform after the company reported "disappointing" Q2 results. In a research note to investors, Eyal says he is moving to the sidelines, as Imperva needs more time to complete its model transition and U.S. restructuring initiatives. The analyst says that while yesterday's after-hours shares' move could be perceived as an attractive valuation level, he would stay away for now.
07/27/18
DADA
07/27/18
DOWNGRADE
Target $46
DADA
Neutral
Imperva downgraded to Neutral at DA Davidson on subscription revenue transition
As reported earlier, DA Davidson analyst Mark Kelleher downgraded Imperva to Neutral from Buy and lowered his price target to $46 from $56. The analyst notes that while the company's focus on the security market and the DDoS opportunity is a positive, the faster than anticipated transition to subscription revenue model is weighing on top-line growth. Kelleher adds that earnings are also constrained by Imperva's acquisition costs, forecasting 2019 as a transition year when the company can work to improve its salesforce productivity.
07/27/18
MONN
07/27/18
DOWNGRADE
MONN
Neutral
Imperva downgraded to Neutral from Buy at Monness Crespi
INTC Intel
$48.74

0.16 (0.33%)

08/24/18
MKMP
08/24/18
NO CHANGE
Target $58
MKMP
Buy
Intel price target lowered to $58 from $61 at MKM Partners
MKM Partners analyst Ruben Roy lowered his price target on Intel to $58, stating that the company's 10nm delays and a lower gross margin profile heading into 2019 warrants a 14-times forward earnings multiple assumption. Longer term, the analyst keeps his Buy rating on Intel, noting that PC demand trends continue to show relative strength as Q2 unit sales rose for the first time in 6 years and top-5 notebook brand volume sales rose 11% in July - the highest rate of growth in 17 months.
08/14/18
JPMS
08/14/18
DOWNGRADE
Target $21
JPMS
Underweight
Macom downgraded to Underweight with $21 price target at JPMorgan
JPMorgan analyst Harlan Sur downgraded Macom Technology Solutions (MTSI) to Underweight with an unchanged price target of $21. With the stock above his price target, the analyst believes the market is already discounting "strong forward earnings power." The analyst also see the potential for margin pressures on current generation discrete Macom-based white box transceiver reference designs for 100G CWDM4 modules amid competition from Intel (INTC), Applied Optoelectronics (AAOI), and InnoLight.
08/10/18
08/10/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Sell from Neutral at Goldman Sachs with analyst Toshiya Hari saying Intel's struggles with 10nm process technology makes the analyst incrementally more negative on the company's competitive positioning and margin outlook. 2. Booking Holdings (BKNG) downgraded to Neutral from Buy at Citi and UBS as well as Neutral from Overweight at JPMorgan. 3. Sysco (SYY) downgraded to Sell from Hold at Pivotal Research with analyst Ajay Jain saying he believes the move up in the stock over the past three months is inconsistent with growing industry headwinds as well as Sysco's company-specific issues. 4. Campbell Soup (CPB) downgraded to Underweight from Neutral at JPMorgan with analyst Ken Goldman saying he agrees with activist Third Point that Campbell's best option is to sell the company; however, he sees a sale as an unlikely outcome. 5. Redfin (RDFN) downgraded to Neutral from Buy at DA Davidson with analyst Tom White citing its Q2 results and below-consensus Q3 guidance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/18
08/10/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GOLDMAN CUTS INTEL, UPGRADES AMD: Goldman Sachs analyst Toshiya Hari downgraded Intel (INTC) to Sell from Neutral and lowered his price target for the shares to $44 from $49. Hari coupled the downgrade with an upgrade of AMD (AMD) to Neutral from Sell. Intel's struggles with 10nm process technology made the analyst incrementally more negative on the company's competitive positioning and margin outlook. He expects a worsening product mix in the near-term, ramp in 10nm costs and growing depreciation to drive margin pressure and Intel's earnings below consensus expectations. The delay in Intel's new products will allow AMD to gain share in not only client computer processing units, and also in the "lucrative" server CPU market, Hari contended. He believes this makes for a balanced risk/reward profile on AMD shares. In late morning trading, Intel is down 2.5% and AMD is up fractionally. BOOKING HOLDINGS DOWNGRADED AT MULTIPLE FIRMS: UBS analyst Eric Sheridan downgraded Booking Holdings (BKNG) to Neutral from Buy and lowered his price target for the shares to $2,060 from $2,320 following the company's Q2 results. JPMorgan analyst Doug Anmuth downgraded Booking Holdings to Neutral from Overweight and lowered his price target for the shares to $2,070 from $2,385. Additionally, Citi analyst Mark May downgraded Booking Holdings to Neutral from Buy and lowered his price target for the shares to $2,150 from $2,350. Booking Holding is down over 2% in late morning trading. JPMORGAN CUTS CAMPBELL SOUP TO UNDERWEIGHT: JPMorgan analyst Ken Goldman downgraded Campbell Soup (CPB) to Underweight from Neutral with a $36 price target, saying he believes a sale of the company at a significant premium is unlikely. Campbell Soup is down over 2% in late morning trading. CANTOR SEES MANY REASONS FOR UNITEDHEALTH ACQUIRING ATHENAHEALTH: Numerous media sources cited a Dealreporter story indicating that UnitedHealth (UNH) is now in the second round of bidding for Athenahealth (ATHN), Cantor Fitzgerald analyst Steven Halper said in a research note. There are "many reasons" why UnitedHealth's Optum would benefit from the acquisition of Athenahealth, the analyst contended. With or without the deal, the analyst expects UnitedHealth will deploy capital and grow its various Optum businesses over time. He reiterated an Overweight rating on shares with a $300 price target.
MU Micron
$51.83

-0.52 (-0.99%)

08/09/18
MSCO
08/09/18
NO CHANGE
MSCO
Morgan Stanley downgrades semiconductor industry view to Cautious
Morgan Stanley analyst Joseph Moore said he has become less constructive on semiconductor stocks through the year and he now believes elevated inventory levels and stretched lead times leave "no margin for error." Given his view that any lead time adjustment or demand slowdown could drive a "meaningful correction," Moore has downgraded his semiconductor industry view to Cautious from In-Line. He favors connector companies, like Amphenol (APH) and TE Connectivity (TEL) over analog/MCU at this point in the cycle, due to lower risk around lead time issues, Moore said. He also has a "strong preference" for high margin and more defensive models, such as Analog Devices (ADI) over lower margin and commodity exposed ones, like Cypress Semiconductor (CY) and ON Semiconductor (ON), he said. Despite his more cautious view on the space, Moore keeps Overweight ratings on Nvidia (NVDA), Xilinx (XLNX) and Ambarella (AMBA), citing his view that they should benefit from secular growth in the area of AI, data center, and autonomous. Other semiconductor names include Microchip (MCHP), Qorvo (QRVO), Micron (MU), Intel (INTC), Broadcom (AVGO) and Qualcomm (QCOM).
08/15/18
WELS
08/15/18
NO CHANGE
Target $63
WELS
Outperform
Micron price target lowered to $63 from $70 at Wells Fargo
Wells Fargo analyst Aaron Rakers lowered his price target for Micron to $63 from $70, while reiterating an Outperform rating on the shares. The analyst believes cycle uncertainties remain, but sees valuation as attractive.
08/15/18
MACQ
08/15/18
NO CHANGE
MACQ
Micron weakness a buying opportunity, says Macquarie
08/16/18
MACQ
08/16/18
NO CHANGE
Target $80
MACQ
Outperform
Micron 'pullback an excellent opportunity,' says Macquarie
Macquarie analyst Srini Pajjuri said Micron has underperformed the SOX index over the past month due to concerns regarding potential DRAM ASP declines. Pajjuri expects declines to be gradual and is modeling mid-single digit decline per quarter over the next 12 months, but would not be surprised if pricing proves to be more resilient as he thinks 2019 industry supply expectat6ions have downside risk. The analyst said shares reflect greater than30% ASP declines and notes DRAM supply is not outpacing demand. Pajjuri views the pullback in Micron as "an excellent opportunity" and reiterates his Outperform rating and $80 price target.
NOW ServiceNow
$200.29

6.04 (3.11%)

07/26/18
ADAM
07/26/18
NO CHANGE
Target $210
ADAM
Buy
ServiceNow price target raised to $210 from $190 at Canaccord
Canaccord analyst Richard Davis raised his price target on ServiceNow to $210 from $190 following Q2 results. The analyst said there was upside across the board with pretty much every metric on track. He noted the company reiterated its full-year guidance and he expects there is potential upside as the year plays out. Davis reiterated his Buy rating on ServiceNow shares.
07/26/18
KEYB
07/26/18
NO CHANGE
Target $210
KEYB
Overweight
ServiceNow price target raised to $210 from $194 at KeyBanc
KeyBanc analyst Rob Owens raised his price target for ServiceNow to $210 from $194, while reiterating an Overweight rating on the shares. With another beat and raise quarter on a constant-currency basis, the company's strong large-deal activity, customer additions, and retention rates suggest the story still has room to run, the analyst contends. He reiterates an Overweight rating on the shares.
07/26/18
JMPS
07/26/18
NO CHANGE
Target $220
JMPS
Outperform
ServiceNow price target raised to $220 from $180 at JMP Securities
JMP Securities analyst Greg McDowell said ServiceNow had a "strong" Q2, highlighting its record 28 deals over $1M in net new annual contract value. Noting that the company's revenue, EPS and subscription billings all topped his estimates, McDowell raised his price target on ServiceNow to $220 and keeps an Outperform rating on the stock.
08/15/18
ARGS
08/15/18
NO CHANGE
Target $215
ARGS
Buy
ServiceNow price target raised to $215 from $201 at Argus
Argus analyst Joseph Bonner raised his price target on ServiceNow to $215 and kept his Buy rating after its "another strong" Q2 that showed a doubling in EPS and a 41% increase in revenue. The analyst cites the company's position of value creation in IT services amid the "secular trend away from the enterprise data center and toward the more easily scalable and cost-effective cloud software-as-a service model", anticipating further revenue and profit growth in the coming few years to support its valuation. Bonner also points to ServiceNow's strong customer retention renewal rate in the upper 90's over the last few years, remaining at 98% in Q2, and a 30% Q2 growth in its total billings.
NTAP NetApp
$86.26

0.32 (0.37%)

08/16/18
JPMS
08/16/18
NO CHANGE
Target $92
JPMS
Overweight
NetApp price target raised to $92 from $85 at JPMorgan
JPMorgan analyst Paul Coster maintained an Overweight rating on NetApp and raised his price target to $92 after the company reported Q1 results that were well above expectations. The stock has re-rated positively over the past two years, owing to the return to growth, and Coster thinks the long-term growth trajectory and earnings growth potential are on the upswing.
08/16/18
LSCM
08/16/18
NO CHANGE
Target $88
LSCM
Buy
NetApp price target raised to $88 from $72 at Lake Street
Lake Street analyst Eric Martinuzzi said the impact of Enterprise License Agreements should not distract investors from the continued strength of NetApp's core all flash array business, adding that the company's operating margin guidance was raised and that its Q2 revenue and EPS guidance is in-line with consensus. Following NetApp's Q1 beat, Martinuzzi reiterated his Buy rating and raised his price target to $88 from $72.
08/16/18
WBLR
08/16/18
NO CHANGE
WBLR
Outperform
NetApp ELAs seen as 'highly strategic' footprint wins, says William Blair
William Blair analyst Jason Ader maintained an Outperform rating on NetApp following its "solid" Q1 results. In a research note to investors, Ader notes that Q2 guidance was $5M below consensus on revenue and "only" in line on EPS, pressuring the stock after-hours on Wednesday, and that ELA accounted for all of the upside in the quarter, and says that while some investors may look "skeptically" on these ELAs, he views the transactions as "highly strategic" footprint wins. Looking ahead, Ader expects product sales growth to continue at a healthy clip.
08/16/18
DADA
08/16/18
NO CHANGE
Target $100
DADA
Buy
NetApp price target raised to $100 from $93 at DA Davidson
DA Davidson analyst Mark Kelleher raised his price target on NetApp to $100 after its better than expected Q1 results, driven by product revenue growth coming from all flash array business as well as the $60M in enterprise license agreements not included in the initial guidance. The analyst also keeps his Buy rating on NetApp, remaining positive on the company's execution of realignment into the Flash storage system market. Kelleher added that the headwind of the company's mature products is moderating while its growth products offer a strong revenue tailwind.
QLYS Qualys
$91.05

-0.5 (-0.55%)

08/01/18
JPMS
08/01/18
NO CHANGE
Target $100
JPMS
Overweight
Qualys price target raised to $100 from $73 at JPMorgan
JPMorgan analyst Sterling Auty raised his price target for Qualys to $100 saying revenue growth in Q2 accelerated again to 23%, up from 22% last quarter. The quarter had 100 basis points of current tailwind, and the benefit of better than anticipated linearity, Auty tells investors in a post-earnings research note. The analyst increased this target multiple for the stock but keeps a Neutral rating on Qualys.
08/01/18
RBCM
08/01/18
NO CHANGE
Target $90
RBCM
Sector Perform
Qualys price target raised to $90 from $80 at RBC Capital
RBC Capital analyst Matthew Hedberg raised his price target on Qualys to $90 and kept his Sector Perform rating after the company's "solid" Q2 results that showed upside in most metrics. Hedberg is positive on the Qualys growth prospects but sees risk-reward as balanced at current valuation.
06/14/18
NEED
06/14/18
NO CHANGE
Target $105
NEED
Buy
Qualys price target raised to $105 from $95 at Needham
Needham analyst Alex Henderson raised his price target on Qualys to $105 after the company's Analyst Day presentation "effectively raised guidance" by providing a long-term projections of over 20% top line growth. Henderson cites continued expansion of functionality driving the company's Security and Network management capabilities, while also "broadening the breadth of its VM security platforms" helping Qualys to sustain its "industry-leading profitability". The analyst keeps his Buy rating on Qualys.
06/14/18
FANA
06/14/18
UPGRADE
Target $110
FANA
Overweight
Qualys upgraded to Overweight from Equal-Weight at First Analysis
First Analysis analyst Howard Smith upgraded Qualys to Overweight and raised his price target for the shares to $110 from $82. The company at its virtual analyst day offered a "compelling" view of its architecture and provided long-range guidance for revenue growth and EBITDA margin above expectations, Smith tells investors in a research note. He believes this allow for continued market outperformance of the shares, despite the "already lofty multiples."
SQ Square
$85.76

4.97 (6.15%)

08/06/18
08/06/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. INTERCEPT DOUBLE UPGRADED AT GOLDMAN: Goldman Sachs analyst Salveen Richter double upgraded Intercept Pharmaceuticals (ICPT) to Buy from Sell and raised his price target for the shares to $157 from $46. The analyst said Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. Intercept should benefit from Ocaliva's global first-mover advantage in NASH, Richter said. In late morning trading, Intercept shares are up 12%. BUCKINGHAM UPGRADES SQUARE TO BUY: Buckingham upgraded Square (SQ) to Buy from Neutral and raised its price target to $85 from $65. Analyst Chris Brendler said the strong Q2 results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better then expected core revenue growth into 2020. Brendler said long-run adjusted EBITDA margins of 40%-50% justify a higher valuation. PIPER CUTS ACADIA TO NEUTRAL: Piper Jaffray analyst Danielle Brill downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Overweight and cut her firm's price target on shares to $19 from $61 after taking over coverage of the name. The recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future, Brill said. Further, the analyst does not have a high level of conviction for positive data from Acadia's near-term catalysts, namely the Phase 2 major depressive disorder data in September and the Phase 2 negative schizophrenia symptoms readout in the first half of 2019. BARCLAYS CUTS INTEL TO EQUAL WEIGHT: Barclays analyst Blayne Curtis downgraded Intel (INTC) to Equal Weight from Overweight and cut his price target for the shares to $53 from $62. The analyst believes upside in the shares will be challenging until the company's margins bottom. JEFFERIES SAYS OHIO INCIDENT NOT A RISK TO CHIPOTLE TRAFFIC: After analyzing digital engagement with the brand from last week and compared to the Virginia incident last July, Jefferies analyst Andy Barish does not believe the illnesses at the Ohio restaurant put Chipotle Mexican Grill's (CMG) traffic trends at risk. The analyst believes Chipotle's procedures were followed in Ohio, the number of cases was not substantiated, and the company did a better job controlling the narrative and taking action. Barish kept a Buy rating on Chipotle shares with a $550 price target.
08/14/18
NOMU
08/14/18
NO CHANGE
Target $86
NOMU
Buy
Square Cash App surpassed PayPal's Venmo for first time in July, says Nomura
Nomura Instinet analyst Dan Dolev raised his price target for Square (SQ) to $86 from $82 after his firm's July payments app tracker showed cumulative Square Cash App downloads surpassed PayPal's (PYPL) Venmo for the first time. Cash App downloads in July of 33.5M marked the highest monthly addition on record, Dolev tells investors in a research note. The analyst says the Square Cash App is growing three times faster than Venmo. He keeps a Buy rating on Square shares.
08/14/18
08/14/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. CREDIT SUISSE INITIATES CASINO STOCKS: Credit Suisse analyst Cameron McKnight initiated Gaming and Leisure Properties (GLPI), VICI Properties (VICI), and PlayAGS (AGS) with an Outperform, Las Vegas Sands (LVS), Wynn Resorts (WYNN), MGM Growth (MGP), and International Game (IGT) with a Neutral, as well as Scientific Games (SGMS) with an Underperform. MORGAN STANLEY RAISES SALESFORCE PRICE TARGET TO $178 FROM $153: Morgan Stanley analyst Keith Weiss raised his price target for Salesforce (CRM) shares to $178 from $153 and maintained an Overweight rating. Weiss noted that unlocking data trapped in legacy systems via MuleSoft brings the company to the forefront of driving digital transformation for its customers and added that consensus expectations likely underestimate its growth potential as well as its improved track record in M&A. JEFFRIES SAYS "SIGNIFICANT SHAREHOLDER VALUE TO BE UNLOCKED" AT NIELSEN: Even following yesterday's 12% rally, there is "significant shareholder value to be unlocked" at Nielsen Holdings (NLSN), Jefferies analyst Surinder Thind told investors in a research note. Nielsen was also upgraded to Outperform from Neutral at Macquarie and to Equal Weight from Underweight at Barclays. Morgan Stanley analyst Toni Kaplan reiterated an Overweight rating and $26 price target on the stock. NOMURA RAISES PRICE TARGET AFTER SQUARE CASH APP SURPASSED PAYPAL'S VENMO IN JULY: Nomura Instinet analyst Dan Dolev raised his price target for Square (SQ) to $86 from $82 after his firm's July payments app tracker showed cumulative Square Cash App downloads surpassed PayPal's (PYPL) Venmo for the first time. SWITCH DOWNGRADED AT MULTIPLE FIRMS: Switch (SWCH) was downgraded to Market Perform from Outperform at Raymond James, to Neutral from Overweight at JPMorgan, and to Neutral from Buy at BTIG. Switch shares are down about 25% in morning trading.
08/29/18
GUGG
08/29/18
NO CHANGE
Target $100
GUGG
Buy
Guggenheim names Square new best idea, raises price target to $100
Guggenheim analyst Jeff Cantwell raised his price target on Square shares to $100 from $75 and named the stock as his new best idea, stating that he thinks subscription and services-based revenues will be stronger than anticipated and that the Cash App has an emerging "butterfly effect" given its key role in providing services to the underbanked. Over the longer-term, Cantwell expects a further buildout of Cash App's services, which he sees as likely to generate significant incremental subscription and services-based revenue for Square, on which he keeps a Buy rating.
SYMC Symantec
$20.58

0.31 (1.53%)

08/21/18
08/21/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Symantec (SYMC) upgraded to Positive from Neutral at Susquehanna with analyst Anne Meisner saying that activist shareholder Starboard Value disclosing a 5.8% stake and nominating five directors to its board has introduced the potential for positive change. 2. Johnson Controls (JCI) upgraded to Buy from Hold at Argus with analyst John Eade citing the company's recent Q3 earnings beat along with the technical breakout in its stock price above the $38 resistance. 3. Discovery (DISCA) upgraded to Buy from Hold at Jefferies with analyst John Janedis saying he sees "several" opportunities that could increase Discovery's free cash flow, including stronger U.S. distribution growth, upside to realized synergies and the potential for a re-introduction of a repurchase earlier than anticipated. 4. Estee Lauder (EL) upgraded to Buy from Neutral at DA Davidson with analyst Linda Bolton Weiser saying the company's fundamentals are the "strongest seen in years," with a 21% rise in FY18 operating profit and an "achievable and potentially beatable" EPS growth outlook of 9%-11% for FY19. 5. Bayer (BAYRY) upgraded to Buy from Hold at Berenberg. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/21/18
SUSQ
08/21/18
UPGRADE
Target $23
SUSQ
Positive
Symantec upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst Anne Meisner upgraded Symantec to Positive from Neutral. The analyst said that activist shareholder Starboard Value disclosing a 5.8% stake and nominating five directors to its Board has introduced the potential for positive change. She now sees more upside than downside from current levels. Meisner raised her price target to $23 from $21 on Symantec shares.
08/21/18
SUSQ
08/21/18
UPGRADE
SUSQ
Positive
Symantec upgraded to Positive from Neutral at Susquehanna
05/16/18
05/16/18
DOWNGRADE
Target $24.5

Neutral
Symantec downgraded to Neutral, another transition year ahead, says Goldman
As previously reported, Goldman downgraded Symantec to Neutral from Buy with a $24.50 price target. Analyst Gabriela Borges expects FY19 to be another transition year with respect to investments, product mix and competitive positioning, compounded by an overhang in the stocks multiple from the May 10 audit investigation.
TWTR Twitter
$35.35

-0.14 (-0.39%)

07/31/18
NOMU
07/31/18
UPGRADE
Target $31
NOMU
Neutral
Twitter upgraded to Neutral from Reduce at Nomura Instinet
Nomura Instinet analyst Mark Kelley upgraded Twitter to Neutral following the recent pullback in the shares. The analyst has a $31 price target for the stock.
07/31/18
NOMU
07/31/18
UPGRADE
Target $31
NOMU
Neutral
Nomura upgrades Twitter to Neutral on reset expectations
Nomura Instinet analyst Mark Kelley upgraded Twitter to Neutral from Reduce with an unchanged price target of $31. The stock closed yesterday down 8%, or $2.74, to $31.38. After selling off 27% since the Q2 earnings report on July 27, expectations have been appropriately reset, Kelley tells investors in a research note. The analyst believes Twitter's investments to clean up the platform will prove a longer term positive and lead to a more engaged user base. Further, he expects improving ad formats will drive advertiser retention and possibly growth over time.
07/31/18
07/31/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Neutral from Reduce at Nomura Instinet analyst Mark Kelley saying after selling off 27% since the Q2 earnings report on July 27, expectations have been appropriately reset. 2. Chipotle (CMG) upgraded to Buy from Hold at Jefferies with analyst Andy Barish saying he believes Chipotle is one of the better positioned companies to benefit from the ongoing shift to digital/off-premise. 3. Affiliated Managers (AMG) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Robert Lee saying he believes the company is positioned for "at least" modest organic growth. 4. Booz Allen (BAH) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Gesuale saying the Q1 report was "stellar," beating every key metric, while the share reaction was "lukewarm." 5. Northrop Grumman (NOC) upgraded to Buy on valuation at Buckingham with analyst Richard Safran saying the sell-off following the Q2 report provides an investment opportunity telling investors Defense spending and recent program wins may not be fully reflected in consensus expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/31/18
07/31/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. JEFFERIES UPS RATING, TARGET FOR CHIPOTLE: Jefferies analyst Andy Barish upgraded Chipotle Mexican Grill (CMG) to Buy from Hold and raised his price target for the shares to $550 from $400. Barish believes Chipotle is one of the better positioned companies to benefit from the ongoing shift to digital/off-premise. The company's operations are now poised to again handle increased volume and throughput, the analyst contended. Further, he believes new management's plans are "credible" and should help drive results in 2019 and beyond. The analyst called the stock a top mid-cap pick. NOMURA UPGRADES TWITTER TO NEUTRAL: Nomura Instinet analyst Mark Kelley upgraded Twitter (TWTR) to Neutral from Reduce with an unchanged price target of $31. After selling off 27% since the Q2 earnings report on July 27, expectations have been appropriately reset, Kelley told investors. The analyst believes Twitter's investments to clean up the platform will prove a longer term positive and lead to a more engaged user base. BARCLAYS PREFERS DEERE TO CATERPILLAR: Barclays analyst Adam Seiden downgraded Caterpillar (CAT) to Equal Weight from Overweight and lowered his price target for the shares to $155 from $170. The company's largest end-markets are no longer at trough, and the analyst believes Caterpillar's second half of 2018 price initiatives, directed towards offsetting supply chain and materials cost increases, will limit its ability to expand margins. The analyst prefers shares of Deere (DE) and CNH Industrial (CNH), which he says are at similar valuations but are earlier in their market cycles. CITI SAYS SELL WISDOMTREE: Citi analyst William Katz placed a low probability on Franklin Resources (BEN) acquiring WisdomTree (WETF), and downgraded WisdomTree to Sell, lowering his price target for the shares to $7 from $10. The analyst downgraded the shares to Neutral on July 13. Katz believes WisdomTree's price-to-earnings multiple can further contract amid mixed flow dynamics and flat earnings growth prospects out to 2020. JPMORGAN SAYS GOPRO MAY SEE SHORT SQUEEZE: JPMorgan analyst Paul Coster believes "muted" expectations and elevated short-interest could position GoPro (GPRO) shares for a "short squeeze" rally after the company's Q2 results. The analyst expects the company to post an in-line quarter. GoPro must entice existing users to upgrade to a new flagship camera expected to be released in early Q4, and convert new users for a product category that "feels a bit long in the tooth now," Coster said. He lowered his price target for GoPro shares to $7 from $8 and kept a Neutral rating on GoPro.
WIX Wix.com
$109.55

0.45 (0.41%)

07/30/18
07/30/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. ADMA Biologics (ADMA) initiated with a Buy at Chardan. 2. Alta Mesa Resources (AMR) initiated with a Buy at Guggenheim. 3. Azure Power (AZRE) initiated with an Outperform at JMP Securities. 4. Exela Technologies (XELA) initiated with a Buy at Nomura Instinet. 5. Wix.com (WIX) initiated with a Neutral at Rosenblatt. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/30/18
RSBL
07/30/18
INITIATION
Target $78
RSBL
Neutral
Wix.com initiated with a Neutral at Rosenblatt
Rosenblatt analyst Mark Zgutowicz initiated Wix.com with a Neutral and $78 price target saying there is little visibility into a long-term scalable model.
07/26/18
KEYB
07/26/18
NO CHANGE
Target $133
KEYB
Overweight
Wix.com price target raised to $133 from $103 at KeyBanc
KeyBanc analyst Alyssa Johnson raised her price target for Wix.com to $133 from $103 as upcoming product potential warrants optimism. With Code pricing not released or baked into guidance, the analyst believes there is still further upside potential over a multiyear period. He reiterates an Overweight rating on the shares.
07/26/18
RHCO
07/26/18
NO CHANGE
Target $120
RHCO
Buy
Wix.com price target raised to $120 from $105 at SunTrust
SunTrust analyst Naved Khan raised his price target on Wix.com to $120 and kept his Buy rating after a beat and raise quarter that also showed strength in conversions, retention, and subscription growth operating metrics. The analyst is also positive on the company's penchant for innovation, potential for improvement in conversions/ARPU, as well as the promising launch of Wix Code.
ZEN Zendesk
$69.27

2.02 (3.00%)

08/01/18
KEYB
08/01/18
NO CHANGE
Target $71
KEYB
Overweight
Zendesk price target raised to $71 from $58 at KeyBanc
KeyBanc analyst Brent Bracelin raised his price target for Zendesk to $71 from $58 on increasing confidence in Zendesk's share gain prospects, clear path to the $1B revenue goal, and secular tailwinds as an enabler of the experience-centric era. The analyst notes that the company's Q2 results impressed on a revenue and billings beat of $4M and $12M, respectively, contributing to a full-year raise of $16M. He reiterates an Overweight rating on the shares.
08/01/18
WELS
08/01/18
NO CHANGE
Target $80
WELS
Outperform
Zendesk price target raised to $80 from $70 at Wells Fargo
Wells Fargo analyst Philip Winslow raised his price target for Zendesk to $80 form $70 after the company reported "strong" second quarter results with revenue, EPS, deferred revenue, and billings above consensus expectations, boosted by Zendesk's suite offering, which is tracking above initial expectations since its launch in May. The analyst reiterates an Outperform rating on the shares.
08/01/18
ADAM
08/01/18
NO CHANGE
Target $65
ADAM
Buy
Zendesk price target raised to $65 from $60 at Canaccord
Canaccord analyst David Hynes raised his price target on Zendesk to $65 from $60 following strong Q2 results. The analyst said the company has taken another step towards its 2020 targets for $1B in revenues. He has increased confidence on the conservatism in the 2020 estimates based on its current revenue acceleration. Hynes reiterated his Buy rating on Zendesk shares.
08/01/18
CHLM
08/01/18
NO CHANGE
Target $68
CHLM
Buy
Zendesk price target raised to $68 form $63 at Craig-Hallum
Craig-Hallum analyst Jeff Van Rhee raised his price target for Zendesk to $68 from $63 after another "big" beat and raise. The analyst reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

14:32
09/22/18
09/22
14:32
09/22/18
14:32
Periodicals
Comcast outbids Fox in battle for Sky, Reuters reports »

Comcast (CMCSA; CMCSK)…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

, COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

13:36
09/22/18
09/22
13:36
09/22/18
13:36
Conference/Events
CoBiz Financial to host special shareholder meeting »

Special Shareholder…

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

AMRH

AMERI Holdings

$1.44

-0.04 (-2.70%)

13:30
09/22/18
09/22
13:30
09/22/18
13:30
Conference/Events
AMERI Holdings to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

13:26
09/22/18
09/22
13:26
09/22/18
13:26
Periodicals
Berkshire Hathaway still looks underpriced, Barron's says »

Class A shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLGO

BioLargo

$0.00

(0.00%)

13:11
09/22/18
09/22
13:11
09/22/18
13:11
Conference/Events
BioLargo to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZWI

Citizens Community Bancorp

$14.13

0.03 (0.21%)

12:56
09/22/18
09/22
12:56
09/22/18
12:56
Conference/Events
Citizens Community Bancorp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SF

Stifel Financial

$54.86

-0.78 (-1.40%)

12:50
09/22/18
09/22
12:50
09/22/18
12:50
Conference/Events
Stifel Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBCT

People's United

$17.94

-0.055 (-0.31%)

, FBNK

First Connecticut

$30.95

0.1 (0.32%)

12:47
09/22/18
09/22
12:47
09/22/18
12:47
Conference/Events
First Connecticut to host special shareholder meeting »

Special shareholder…

PBCT

People's United

$17.94

-0.055 (-0.31%)

FBNK

First Connecticut

$30.95

0.1 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 18

    Oct

ASPS

Altisource

$34.10

-0.09 (-0.26%)

12:44
09/22/18
09/22
12:44
09/22/18
12:44
Conference/Events
Altisource to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, CSCO

Cisco

$48.51

0.77 (1.61%)

12:36
09/22/18
09/22
12:36
09/22/18
12:36
Periodicals
Apple, Microsoft among stocks with solid dividends, Barron's says »

Technology stocks are not…

AAPL

Apple

$217.65

-2.35 (-1.07%)

CSCO

Cisco

$48.51

0.77 (1.61%)

IBM

IBM

$151.29

0.12 (0.08%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

ORCL

Oracle

$51.08

0.65 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 10

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

CAT

Caterpillar

$156.39

0.38 (0.24%)

, AMAT

Applied Materials

$39.62

0.22 (0.56%)

12:28
09/22/18
09/22
12:28
09/22/18
12:28
Periodicals
Caterpillar, KeyCorp among stocks to buy as bond yields rise, Barron's says »

As the economy improves,…

CAT

Caterpillar

$156.39

0.38 (0.24%)

AMAT

Applied Materials

$39.62

0.22 (0.56%)

BWA

BorgWarner

$45.24

-0.53 (-1.16%)

KEY

KeyCorp

$20.78

0.02 (0.10%)

PH

Parker-Hannifin

$190.52

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 18

    Oct

  • 25

    Oct

  • 30

    Oct

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

, ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

10:34
09/22/18
09/22
10:34
09/22/18
10:34
Periodicals
'Good time' to think about device markers, Barron's says »

Medical technology stocks…

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

TLRY

Tilray

$123.16

-53.365 (-30.23%)

10:20
09/22/18
09/22
10:20
09/22/18
10:20
Periodicals
Marijuana stocks 'the new Bitcoin,' Barron's says »

Led by Tilray, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, WMT

Walmart

$95.85

0.1 (0.10%)

09:05
09/22/18
09/22
09:05
09/22/18
09:05
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$217.65

-2.35 (-1.07%)

WMT

Walmart

$95.85

0.1 (0.10%)

DE

Deere

$152.82

-1.24 (-0.80%)

AGCO

Agco

$60.24

-0.9 (-1.47%)

ADM

Archer Daniels

$50.33

(0.00%)

MOS

Mosaic

$32.33

0.02 (0.06%)

CF

CF Industries

$52.82

-0.48 (-0.90%)

SPWR

SunPower

$7.88

-0.18 (-2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 06

    Nov

  • 13

    Nov

  • 15

    Nov

  • 03

    Mar

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

, AGN

Allergan

$191.34

-1.11 (-0.58%)

04:55
09/22/18
09/22
04:55
09/22/18
04:55
Conference/Events
European Society of Retina Specialists to hold a conference »

18th Congress of EURETINA…

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

AGN

Allergan

$191.34

-1.11 (-0.58%)

ALIM

Alimera Sciences

$1.07

(0.00%)

BABY

Natus Medical

$34.45

-0.2 (-0.58%)

BHC

Bausch Health

$24.92

-0.07 (-0.28%)

BAYRY

Bayer

$0.00

(0.00%)

ELXMF

Ellex Medical Lasers

$0.00

(0.00%)

GKOS

Glaukos

$58.78

-1.69 (-2.79%)

IRIX

IRIDEX

$6.52

0.08 (1.24%)

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

OCUL

Ocular Therapeutix

$6.45

0.03 (0.47%)

RHHBY

Roche

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

TMDI

Titan Medical

$2.24

0.02 (0.90%)

TTNP

Titan Pharmaceuticals

$0.22

-0.2833 (-56.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 09

    Oct

  • 16

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 15

    Nov

  • 27

    Nov

  • 21

    Dec

  • 28

    Dec

  • 15

    Feb

  • 25

    Feb

CDTI

CDTi

$0.34

0.01 (3.08%)

18:15
09/21/18
09/21
18:15
09/21/18
18:15
Hot Stocks
CDTi sees September 21 as effective date of reverse stock split »

CDTi Advanced Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$79.82

-0.81 (-1.00%)

18:08
09/21/18
09/21
18:08
09/21/18
18:08
Hot Stocks
Duke Energy restored nearly 1.8M outages in NC, SC during past week »

Duke Energy crews today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 11

    Nov

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

18:01
09/21/18
09/21
18:01
09/21/18
18:01
Hot Stocks
Johnson & Johnson's Janssen discloses phase 3 study results of Esketamine »

The Janssen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

UAL

United Continental

$89.94

0.8 (0.90%)

17:39
09/21/18
09/21
17:39
09/21/18
17:39
Periodicals
United pilots refuse contract changes on regional routes, Reuters says »

United Airlines pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

, XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

17:36
09/21/18
09/21
17:36
09/21/18
17:36
General news
Week ending ETF Scorecard: Materials outperform, Utlilites slump »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

IYR

DJ US Real Estate Index Fund

$81.88

-0.06 (-0.07%)

XLP

Consumer Staples Sector SPDR

$55.02

0.1285 (0.23%)

XLY

Consumer Discretionary Sector SPDR

$116.98

-0.4288 (-0.37%)

XLB

S&P Select Materials SPDR

$60.54

-0.1312 (-0.22%)

XLF

Financial Select Sector

$28.73

-0.1175 (-0.41%)

XLV

Health Care Select Sector SPDR

$94.26

0.1571 (0.17%)

XLK

Technology Select Sector SPDR

$74.68

-0.2056 (-0.27%)

XLI

Industrial Select Sector SPDR

$79.71

0.2338 (0.29%)

GLD

SPDR Gold Trust

$113.48

-0.77 (-0.67%)

SLV

iShares Silver Trust

$13.44

-0.01 (-0.07%)

USO

United States Oil Fund

$14.95

0.145 (0.98%)

UNG

United States Natural Gas Fund

$24.60

0.235 (0.96%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.24

0.05 (0.06%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$114.72

0.04 (0.03%)

TLT

iShares 20+ Year Treasury Bond Fund

$117.12

-0.02 (-0.02%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.00

0.03 (0.03%)

SHY

iShares 1-3 Year Treasury Bond

$83.05

0.02 (0.02%)

IWD

iShares Russell 1000 Value

$129.51

0.13 (0.10%)

IWF

iShares Russell 1000 Growth

$155.30

-0.55 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHGI

One Horizon Group

$0.18

-0.0088 (-4.63%)

17:34
09/21/18
09/21
17:34
09/21/18
17:34
Syndicate
Breaking Syndicate news story on One Horizon Group »

One Horizon Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.41

-0.033 (-7.38%)

17:31
09/21/18
09/21
17:31
09/21/18
17:31
Syndicate
Breaking Syndicate news story on Cytori Therapeutics »

Cytori Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Mining

$31.56

0.05 (0.16%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Syndicate
Breaking Syndicate news story on Newmont Mining »

Newmont Mining files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Oct

CB

Chubb

$139.87

-0.05 (-0.04%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Hot Stocks
Chubb CEO Greenberg sells $8.6M in common stock »

Chubb CEO Evan Greenberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$0.80

0.0096 (1.21%)

17:21
09/21/18
09/21
17:21
09/21/18
17:21
Hot Stocks
vTv says FDA advised that azeliragon efficacy be shown in at least 2 trials »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.